Applied Physiology Raises $5 Million for Navigator™ Mar...( Medical devi...),Health

Medical device company Applied Physiology this week closed a $5 million Series B round of investment with GBS Venture Partners as AP prepares for market launch of its Navigator™ circulation guidance system.

Sydney, NSW, Australia (PRWEB) July 24, 2009 -- Medical device company Applied Physiology Pty Ltd (AP), a developer of circulation guidance systems for critically-ill patients, announced today a Series B $5 million investment from Series A lead investor GBS Venture Partners, Australia.

Managing critically-ill patients is complex and costly. Today, most patient monitoring and clinical information systems offer clinicians little guidance to rationalize and standardize treatment. Consequently, hospitals are increasingly seeking clinical decision support tools in an effort to address these problems and reduce cost.

"AP's Navigator takes data from standard cardiovascular monitors and assembles it into graphical treatment guidance for clinicians, making continuous goal directed therapy a reality" says Dr. Steve Gourlay, general partner of GBS. "We see great potential to improve patient outcomes while reducing the cost and complexity of acute care. We continue to back Applied Physiology both for its breakthrough technology and the strong management team."

The novel Navigator technology determines the volume, resistance and heart components of standard cardiovascular signals, such as blood pressure, and then arranges them in a form that guides medical staff towards therapeutic o
'/>"/>